AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Efficacy and Tolerance Study of B-DYN Versus Conventional Fusion in the Treatment of Lumbar Stenosis on the Degree of Post-operative Functional Incapacity (BDYNCLIN)

RecruitingNAAges 40 Years - anyAllQuanta Medical
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Degenerative Lumbar Spinal Stenosis (LSS) is an extremely common condition affecting more than 102 million people each year. It is a narrowing of the spinal canal in the lower back. It causes pain and even disorders of the lower limbs. When the symptoms get worse and the individual feels functional discomfort despite medical treatment, surgical intervention is recommended. Two surgical options are available: Rigid Stabilization Devices as conventional fusion with or without cage, or dynamic stabilization system as B-DYN device, this system is called "dynamic" because it allows the stabilization of the operated part while preserving a certain mobility. The main objective of this study is to evaluate the efficacy and tolerance of B-Dyn versus conventional bolted fusion (with or without cage) in the treatment of degenerative lumbar stenosis (DLS) on the degree of postoperative functional i

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Disease related criteria: 1. Stenosis on 1, 2 or 3 disc levels (grade B or C or D according to Schizas classification or central stenosis of grade A according to Schizas classification with a lateral stenosis (postero-lateral overhang or disc protrusion)) on MRI (lumbar spine MRI ) 2. Spondylolisthesis grade 1 or no the upper surgical (treated) level 3. Neurological impairment or neurogenic claudication on one or both legs (VAS score \> 30) 4. Subjects who have failed well-managed medical treatment that has not resulted in long-lasting symptom relief (duration of symptoms \> 3 months); 5. Subjects with no contraindication to fusion or the application of B-Dynยฎ. Population-related criteria 1. Subjects of both sexes, 40 years of age and older 2. Subjects who have given free, informed and written consent to participate in the study; 3. Subjects who are able to respond to questionnaires and who can communicate in the language of the study country ; 4. Subjects affiliated to a social security scheme or entitled to a social security scheme. Exclusion Criteria: Disease related criteria: 1. Spondylolisthesis of grade \> 1 on the upper surgical (treated) level 2. Intervention required on more than 3 disc levels 3. Degenerative Scoliosis (Cobb angle \> 20ยฐ); 4. Stenosis located only on the L5-S1 level 5. History of instrumented lumbar surgery (cage, rod, etc.) on the upper or lower level, except in the case of instrumentation of the lower level with an intra-spinous device. 6. Stenosis not caused by from degenerative changes. 7. Isolated disc herniation 8. Other specific vertebral damage (for example: ankylosing spondylitis, cancer or neurological disorders) 9. History of vertebral compression fractures at the instrumented level 10. History of osteoporotic fractures 11. Psychological disorders (e.g. dementia โ€ฆ.etc) or drug addiction that lead to an inability to participate in the study 12. Chronic infection Population related criteria: 1. Withdrawal of consent; 2. Pregnant or Breastfeeding woman 3. Participation in a clinical trial in the 3 months prior to the initial visit; 4. Predicted unavailability during study. Patient deprived of liberty or under guardianship. Medical Device related criteria: 1\. Allergy to any of the components of the medical device.
๐Ÿ’Š

What it tests

  • B-DYN
  • Conventional Bolted fusion (with or without cage)
๐Ÿ“

Where

2 sites
CHU [University Hospital Center]of Bordeaux - Le Tripode - GH Pellegrin/ Department of Orthopaedic and Trauma Surgery Spinal Surgery Unit
Bordeaux, France
Clinique Des Cedres
Cornebarrieu, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy